Search International and National Patent Collections

1. (WO2018053073) METHOD OF USE OF ERITORAN AS A TLR4 ANTAGONIST FOR TREATMENT OF EBOLA AND MARBURG DISEASE

Pub. No.:    WO/2018/053073    International Application No.:    PCT/US2017/051472
Publication Date: Fri Mar 23 00:59:59 CET 2018 International Filing Date: Fri Sep 15 01:59:59 CEST 2017
IPC: A61K 31/00
A61K 31/7024
A61P 31/14
Applicants: EISAI R&D MANAGEMENT CO., LTD.
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Inventors: BUKREYEV, Alexander
GUSOVSKY, Fabian
YOUNAN, Patrick
EVERSON, Michael
Title: METHOD OF USE OF ERITORAN AS A TLR4 ANTAGONIST FOR TREATMENT OF EBOLA AND MARBURG DISEASE
Abstract:
The present invention is directed to methods for treating ebola virus infections or Marburg virus infections comprising administering to a subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof.